Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 606

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

X-linked Alport Syndrome: Natural History in 195 Families and Genotype- Phenotype Correlations in Males

JAIS, JEAN PHILIPPE, KNEBELMANN, BERTRAND, GIATRAS, IANNIS, MARCHI, MARIO DE, RIZZONI, GIANFRANCO, RENIERI, ALESSANDRA, WEBER, MANFRED, GROSS, OLIVER, NETZER, KAI-OLAF, FLINTER, FRANCES, PIRSON, YVES, VERELLEN, CHRISTINE, WIESLANDER, JÖRGEN, PERSSON, ULF, TRYGGVASON, KARL, MARTIN, PAULA, HERTZ, JENS MICHAEL, SCHRÖDER, CORNELIS, SANAK, MAREK, KREJCOVA, SARKA, CARVALHO, MARIA FERNANDA, SAUS, JUAN, ANTIGNAC, CORINNE, SMEETS, HUBERT, GUBLER, MARIE CLAIRE·2000·Journal of the American Society of Nephrology

Abstract

Abstract.: Alport syndrome (AS) is a type IV collagen hereditary disease characterized by the association of progressive hematuric nephritis, hearing loss, and, frequently, ocular changes. Mutations in the COL4A5 collagen gene are responsible for the more common X-linked dominant form of the disease. Considerable allelic heterogeneity has been observed. A “European Community Alport Syndrome Concerted Action” has been established to delineate accurately the AS phenotype and to determine genotype-phenotype correlations in a large number of families. Data concerning 329 families, 250 of them with an X-linked transmission, were collected. Characteristics of the 401 male patients belonging to the 195 families with COL4A5 mutation are presented. All male patients were hematuric, and the rate of progression to end-stage renal failure and deafness was mutation-dependent. Large deletions, nonsense mutations, or small mutations changing the reading frame conferred to affected male patients a 90% probability of developing end-stage renal failure before 30 yr of age, whereas the same risk was of 50 and 70%, respectively, in patients with missense or splice site mutation. The risk of developing hearing loss before 30 yr of age was approximately 60% in patients with missense mutations, contrary to 90% for the other types of mutations. The natural history of X-linked AS and correlations with COL4A5 mutations have been established in a large cohort of male patients. These data could be used for further evaluation of therapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.v114649

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 606

Metadata

Authors
JAIS, J. P., KNEBELMANN, B., GIATRAS, I., MARCHI, M. D., RIZZONI, G., RENIERI, A., WEBER, M., GROSS, O., NETZER, K.-O., FLINTER, F., PIRSON, Y., VERELLEN, C., WIESLANDER, J., PERSSON, U., TRYGGVASON, K., MARTIN, P., HERTZ, J. M., SCHRÖDER, C., SANAK, M., KREJCOVA, S., CARVALHO, M. F., SAUS, J., ANTIGNAC, C., SMEETS, H., & GUBLER, M. C.
Venue
Journal of the American Society of Nephrology
Published
2000-04
Volume
11
Issue
4
Pages
649-657
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2128796050
Cited by
606
References
15
FWCI
10.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: X-linked Alport Syndrome: Natural History in 195 Families and Genotype- Phenotype Correlations in Males. https://app.cochat.ai/papers/10.1681/asn.v114649
The paper
JAIS, J. P., KNEBELMANN, B., GIATRAS, I., MARCHI, M. D., RIZZONI, G., RENIERI, A., WEBER, M., GROSS, O., NETZER, K.-O., FLINTER, F., PIRSON, Y., VERELLEN, C., WIESLANDER, J., PERSSON, U., TRYGGVASON, K., MARTIN, P., HERTZ, J. M., SCHRÖDER, C., SANAK, M., . . . GUBLER, M. C. (2000). X-linked Alport Syndrome: Natural History in 195 Families and Genotype- Phenotype Correlations in Males. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v114649

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.